NO20003138L - New application of local anesthetics to vascular headaches - Google Patents

New application of local anesthetics to vascular headaches

Info

Publication number
NO20003138L
NO20003138L NO20003138A NO20003138A NO20003138L NO 20003138 L NO20003138 L NO 20003138L NO 20003138 A NO20003138 A NO 20003138A NO 20003138 A NO20003138 A NO 20003138A NO 20003138 L NO20003138 L NO 20003138L
Authority
NO
Norway
Prior art keywords
new application
local anesthetics
vascular headaches
alkyl
vascular
Prior art date
Application number
NO20003138A
Other languages
Norwegian (no)
Other versions
NO20003138D0 (en
Inventor
Carl-Johan Dalsgaard
Arne Eek
Lennart Waldenlind
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20003138D0 publication Critical patent/NO20003138D0/en
Publication of NO20003138L publication Critical patent/NO20003138L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ny anvendelse av en forbindelse av formel (I) hvor R1 representerer C3.5 alkyl; og R2 og R3 representerer uavhengig Ci-3 alkyl; eller et farmasøytisk akseptabelt salt derav, for fremstilling av et legemiddel for behandling av en vaskulær hodepinetilstand, spesielt migrene.New use of a compound of formula (I) wherein R1 represents C3.5 alkyl; and R 2 and R 3 independently represent C 1-3 alkyl; or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of a vascular headache condition, especially migraine.

NO20003138A 1997-12-19 2000-06-16 New application of local anesthetics to vascular headaches NO20003138L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (en) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (2)

Publication Number Publication Date
NO20003138D0 NO20003138D0 (en) 2000-06-16
NO20003138L true NO20003138L (en) 2000-08-18

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003138A NO20003138L (en) 1997-12-19 2000-06-16 New application of local anesthetics to vascular headaches

Country Status (18)

Country Link
EP (1) EP1047412A1 (en)
JP (1) JP2001526217A (en)
KR (1) KR20010024768A (en)
CN (1) CN1282241A (en)
AU (1) AU1898199A (en)
BR (1) BR9813775A (en)
CA (1) CA2314452A1 (en)
EE (1) EE200000394A (en)
HU (1) HUP0100599A3 (en)
ID (1) ID26703A (en)
IL (1) IL136518A0 (en)
IS (1) IS5534A (en)
NO (1) NO20003138L (en)
PL (1) PL341283A1 (en)
SE (1) SE9704770D0 (en)
SK (1) SK7832000A3 (en)
TR (1) TR200001926T2 (en)
WO (1) WO1999032103A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6491940B1 (en) 1999-01-27 2002-12-10 Bruce H. Levin Apparatus for administering composition for inhibiting cerebral neurovascular disorders and muscular headaches
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
JP6568099B2 (en) 2014-03-21 2019-08-28 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ Antagonist antibody against calcitonin gene-related peptide and method of use thereof
KR20180058777A (en) * 2015-09-24 2018-06-01 테바 파마슈티컬스 인터내셔널 게엠베하 (Persistence) prevention, treatment and reduction of post-traumatic headache
KR20220031944A (en) 2016-09-23 2022-03-14 테바 파마슈티컬스 인터내셔널 게엠베하 Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (en) * 1958-11-06 1964-08-15 Ciba Geigy Process for the preparation of new secondary amines
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (en) * 1995-10-27 1999-03-10 Astrazeneca Ab NEW DERIVATIVES OF [3-ALCOXI-PENOXI -) - ETIL] -DIALKYLAMINE, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, THEIR USE AS LOCAL ANESTHETICS AND A PROCEDURE FOR THEIR PREPARATION

Also Published As

Publication number Publication date
HUP0100599A3 (en) 2002-04-29
ID26703A (en) 2001-02-01
WO1999032103A1 (en) 1999-07-01
PL341283A1 (en) 2001-04-09
EE200000394A (en) 2001-12-17
SE9704770D0 (en) 1997-12-19
AU1898199A (en) 1999-07-12
CN1282241A (en) 2001-01-31
CA2314452A1 (en) 1999-07-01
SK7832000A3 (en) 2001-02-12
HUP0100599A2 (en) 2002-02-28
IS5534A (en) 2000-06-15
IL136518A0 (en) 2001-06-14
KR20010024768A (en) 2001-03-26
EP1047412A1 (en) 2000-11-02
BR9813775A (en) 2000-10-10
NO20003138D0 (en) 2000-06-16
TR200001926T2 (en) 2000-11-21
JP2001526217A (en) 2001-12-18

Similar Documents

Publication Publication Date Title
SE9604786D0 (en) New compounds
CA2260337A1 (en) Therapeutic agents
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
NO996108L (en) 9 oksinerytromycinderivater
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
RU94044436A (en) Method of suppression of skin and vagina atrophy
NO166126C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLONCARBOXYLIC ACID DERIVATIVES.
UA27910C2 (en) Method of increasing thrombomodulin expression and increasing protein c activation rate
RU94045271A (en) Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition
NO20003138L (en) New application of local anesthetics to vascular headaches
RU94044357A (en) Use of 2-phenyl-3-aroylbenzothiophenes for inhibiting weight increase, inducing weight decrease or inhibiting appetite
ATE212996T1 (en) ANTHRACYCLINE DERIVATIVES
EP0273266A3 (en) Medicament containing a silicon derivative of menthol
SE9702716D0 (en) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
WO1994003425A3 (en) Carbostyril derivatives for the treatment of arrhythmia
NO922151L (en) GINGEROL AND GINGERDIOLD DERIVATIVES AS HYPOCOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS
DK0556813T3 (en) Amphoteric tricyclic compounds such as antihistamine and antiallergic agents
SE9800905D0 (en) New therapy in glomerulonephritis
DE68909025T2 (en) Anti-plaque agent.
DE69619088T2 (en) Quinoxaline derivatives used to treat tinnitus
CA2377230A1 (en) Benzimidazole compounds and medicaments comprising the same
EP0461264A4 (en) Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
ATE228359T1 (en) INHIBITION OF LEUKOTRIE BIOSYNTHESIS USING UREA DERIVATIVES
SE9603284D0 (en) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application